KB707-02: inhaled KB707 for lung-related advanced solid tumors
Автор: VJOncology
Загружено: 2025-06-04
Просмотров: 85
Описание:
Wen Wee Ma, MBBS, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, safety and preliminary efficacy findings from the Phase I/II KB707-02 study (NCT06228326), evaluating inhaled KB707 monotherapy in patients with advanced solid tumors involving the lungs. KB707, a herpes simplex virus–based vector encoding IL-12 and IL-2, demonstrated a favorable safety profile with no severe treatment-related toxicities. The study has now expanded to assess combination strategies with pembrolizumab for non-small cell lung cancer. This interview took place during the 2025 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
